Company intelligence / Profile preview

Sidec Technologies

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Sidec Technologies was a Swedish biotechnology company specializing in advanced 3D imaging of proteins. The company developed a proprietary technology called Protein Tomography, which allowed for the visualization of individual protein molecules and their interactions within cells or in purified samples. This technology provided high-resolution structural information that was used to accelerate drug discovery and development processes. In 2008, Sidec was acquired by FEI Company, a leading provider of electron microscopy solutions, to integrate its software and imaging capabilities into FEI's life sciences portfolio.

Modalities: ProteinAntibody
Industry: Medical Imaging

Partnerships

AstraZenecaPfizerAmgen

Beyond the preview

Go deeper on Sidec Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sidec Technologies.

Explore the full profile